Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given an average rating of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price […]
Terns Pharmaceuticals, Inc (NASDAQ:TERN) Receives $16 11 Average Price Target from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $10.00 to $11.00 in a report published on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts have also recently issued research reports about the stock. Roth Mkm […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) has been assigned an average rating of “Moderate Buy” from the nine research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective […]
Research analysts at Mizuho started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “buy” rating and a $16.00 price target on the stock. Mizuho’s price target suggests a potential upside of 46.25% from the company’s current price. A number […]